Carl Zeiss Meditec (ETR:AFX) Trading Up 0% – What’s Next?

Shares of Carl Zeiss Meditec AG (ETR:AFX) shot up 0% during mid-day trading on Wednesday . The company traded as high as €41.74 and last traded at €41.20. 72,923 shares traded hands during mid-day trading, a decline of 23% from the average session volume of 94,405 shares. The stock had previously closed at €41.18.

Carl Zeiss Meditec Price Performance

The company has a quick ratio of 2.47, a current ratio of 2.13 and a debt-to-equity ratio of 7.41. The firm has a market cap of $3.84 billion, a P/E ratio of 22.02, a PEG ratio of 2.83 and a beta of 0.98. The business has a fifty day moving average of €41.95 and a 200 day moving average of €44.78.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.